title: Some HER2-Negative Breast Tumors May Respond to HER2-Targeted Treatment.
authors.forename: Sue
authors.initials: S
authors.lastname: Rochman
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D009154:Mutation / Q000235:genetics; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases